Otsuka
Otsuka is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Otsuka products.
Drugs from Otsuka supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Voyxact | sibeprenlimab-szsi | Nephrology (Rare) | Proteinuria reduction in primary IgA nephropathy (IgAN) at risk of progression |
How NPP access to Otsuka products works
Reserve Meds sources Otsuka products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Otsuka
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Otsuka.